*Pleasing progress for China label and English label (CBEC) infant formula sales.
*Continued strengthening of infant formula market share position (China & ANZ).
*Continuing positive momentum in sales velocities in the US
Everything on track, management continuing to deliver as the balance street continues to get stronger.